Brooke Read

Neonatal Respiratory Therapist, Co-Chair of the EPIQ Lung Health Group @EPIQ_LHG. Passionate about neonatal lung health and QI in the NICU. 🇨🇦

[EPIQ Lung Health Group @EPIQ_LHG]

Reducing delivery room intubation = a key step in lowering BPD risk in preterm infants. Canadian Neonatal Network data shows variation across sites -highlighting an opportunity to improve outcomes through strategies that prioritize non-invasive respiratory support at birth.

[EPIQ Lung Health Group @EPIQ_LHG]

EPIQ LHG Article of the Month (April 2026): Surfactant-budesonide combination to prevent death or bronchopulmonary dysplasia: a systematic review and meta-analysis https://t.co/sYHAT6pBjK

[EPIQ Lung Health Group @EPIQ_LHG]

EPIQ LHG Article of the Month (February 2026): Prophylactic Hydrocortisone and Bronchopulmonary Dysplasia in Preterm Infants https://t.co/xJeuHU4XQX

[EPIQ Lung Health Group @EPIQ_LHG]

We had a great discussion during the LHG breakout session at the 2026 EPIQ conference! We received great feedback on the development of a standardized approach to postnatal steroids and heard about the implementation of SALSA in a Level 2 NICU. 🫁 @CNN_EPIQ

[EPIQ Lung Health Group @EPIQ_LHG]

Join us for our next EPIQ Grands Rounds on November 26 @ 1 pm EST highlighting the QI work happening at Mount Sinai Hospital to improve Lung Health and further preterm respiratory research. Zoom link: https://t.co/S4Rfxzxqqn

[EPIQ Lung Health Group @EPIQ_LHG]

We are pleased to release our first Journal Club commentary, provided by : Dr. Elizabeth Asztalos on: Postnatal dexamethasone treatment for preterm infants at high risk for bronchopulmonary dysplasia is associated with improved regional brain volumes: a prospective cohort study

[EPIQ Lung Health Group @EPIQ_LHG]

Join us for EPIQ Grand Rounds on March 20, 2025 3-4 pm EST. No need to register just join the link. @CNN_EPIQ https://t.co/9JyfcdxyOA

[EPIQ Lung Health Group @EPIQ_LHG]

LHG Article of the Month November 2024: Intratracheal Budesonide Mixed With Surfactant for Extremely Preterm Infants: The PLUSS Randomized Clinical Trial | Clinical Pharmacy and Pharmacology | JAMA | JAMA Network https://t.co/R7Ew0y6gF7

[EPIQ Lung Health Group @EPIQ_LHG]

We are excited to share that we are hosting the next EPIQ Grand Rounds session on September 11, 2024 at 1PM EST on the topic of LISA, presented by Dr. Wolfgang Göpel from the German Neonatal Network. No registration required, just join Zoom link, found in comments. @CNN_EPIQ

[Brooke Read @brookeread7]

Still lots of work to be done to improve patient safety across the world. WHO: Global patient safety report 2024 (30 May 2024) - WHO - Patient Safety Learning - the hub https://t.co/lGvMRN2GhX

[Brooke Read @brookeread7]

#kangaroocareawarenessday 🦘#kangaroocare

[Brooke Read @brookeread7]

Happy Kangaroo Care Awareness Day! This day is extra important to me having been both a parent and a staff member in NICU. Facilitating this special time between infants and their families helps to make a stressful time easier. #kangaroocare

[EPIQ Lung Health Group @EPIQ_LHG]

The recording of our recent EPIQ Grands Rounds with @guisantanna is now available on the EPIQ website https://t.co/dfemyjvcka
@CNN_EPIQ #neotwitter #CNNneonatal

[EPIQ Lung Health Group @EPIQ_LHG]

EPIQ LHG Article of the Month (April 2024): Azithromycin therapy for prevention of chronic lung disease of prematurity (AZTEC): a multicentre, double-blind, randomised, placebo-controlled trial - The Lancet Respiratory Medicine https://t.co/2PcFRAsbBD

[Damian H Adams @damian_h_adams]

International Donor Conception Awareness Day #DonorConception

[EPIQ Lung Health Group @EPIQ_LHG]

Join us on April 17 at 2 pm EST where the EPIQ Lung Health Group will be hosting EPIQ Grand Rounds with Dr. Sant’Anna. No need to register just join the Zoom link. @CNN_EPIQ

[Brooke Read @brookeread7]

Proud to have been part of this important work!

[Amit Mukerji, MD, MSc, FRCP(C) @mukerji_amit]

In our CER study in >1,800 preterm neonates using real-world data, post-extubation CPAP as utilized had a higher risk of "failure", but was non-inferior to NIPPV for the risk of re-intubation. @CNN_EPIQ @EPIQ_LHG @nicupodcast @EBNEO @CIHR_IHDCYH https://t.co/yiEx6oFpMN

[EPIQ Lung Health Group @EPIQ_LHG]

Care to weigh in Canada? Data from 2022 @CNN_EPIQ report shows use of LISA/MIST for first dose of surfactant is approximately 20% in infants born at less than 32 weeks gestation. Highest use is in 26-32 weeks. More work to be done to increase uptake of MIST in Canada @drbretty

[EPIQ Lung Health Group @EPIQ_LHG]

We had a great discussion at our LHG breakout session at the EPIQ Conference discussing extubation hesitancy with @AymanAbouMehrem. A closer look at the evidence challenges some common practices with regards to extubation. #CNNneonatal @CNN_EPIQ

[EPIQ Lung Health Group @EPIQ_LHG]

A snapshot of our Lung Health Group poster presentation session at the EPIQ Conference. Lots of great work being done to target improved outcomes in Lung Health. 🫁🇨🇦 #EPIQ2024 @CNN_EPIQ

[Brooke Read @brookeread7]

Enjoying the views before the EPIQ conference in Banff, Alberta. 🇨🇦@CNN_EPIQ